BioSpace News Archive

Coherus BioSciences, Inc. announced the Company has entered into a licensing agreement with Innovent Biologics, Co., Ltd.,, a leading biopharmaceutical company headquartered in China, to commercialize Innovent’s biosimilar candidate to Avastin® in the United States and Canada.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-house developed antiepileptic drug Fycompa for an additional indication for monotherapy of partial-onset seizures and an additional indication for partial-onset seizures in pediatric patients aged 4 years and older, as well as a new fine granule formulation.

The drug, a checkpoint inhibitor, met the primary endpoint of improved progression-free survival at the planned interim analysis.

Bill Doyle, executive chairman of the board of directors for NovoCure, said 2019, which included the U.S. approval of the first treatment for mesothelioma in 15 years, was an incredible year “on all fronts” for the company.

Cerus Corporation (Nasdaq:CERS) today announced the publication of a study in Transfusion Medicine1 on the inactivation of the MERS (Middle Eastern Respiratory Syndrome) coronavirus in human platelet concentrates using the INTERCEPT Blood System for platelets.

CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced the launch of its updated PlusCBD™ Oil website: www.pluscbdoil.com.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc.

LifeNet Health, the Virginia-based Organ Procurement Organization (OPO), facilitated a record 585 organ transplants in 2019, exceeding the previous year’s record of 497 transplants.

Despite healthcare providers’ widespread adoption of web-based patient portals, about one-third of consumers report they have never used one to view their medical records, according to a recent survey conducted by DrFirst, a pioneer in technology, support, and services that connect people at touchpoints of patient care